APLS Apellis Pharmaceuticals Net earnings per share (EPS TTM)

Graphic logo of apellis.com (APLS)

Apellis Pharmaceuticals (APLS) operates in an environment of fierce competition for the patent purity of its drugs. The company's TTM net income per share shows a turning point driven by the implementation of robotic bio-screening and a steady cash flow from geographic atrophy therapy. The value of 1.00 determines the current status of the parameter, capturing the final dynamics of accumulated earnings per share.

APLS Apellis Corp Net earnings per share for the last four quarters (07/04/2022 - 05/30/2026)

Comprehensive metric breakdowns and analytics for Apellis Pharmaceuticals, Inc. (APLS)

- share price and expert price forecast:
Stock Quotes Apellis Pharmaceuticals|APLS - Average Forecast Price
- market capitalization data:
Market Capitalization Apellis|APLS - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Apellis Pharmaceuticals|APLS - Book Valuation of Business|Market Capitalization to Book Value Ratio apellis.com|APLS - Company Total Assets
- debt and liquidity details:
Debt to Equity Apellis Pharmaceuticals|APLS - Long-Term Liabilities to Equity|Short-Term Debt to Capital Apellis Pharmaceuticals Inc|APLS - Company Cumulative Debt|Debt to Book Capitalization Ratio Apellis|APLS - Company Long-Term Debt|Company Short-Term Debt Apellis Pharmaceuticals|Quick Ratio apellis.com
- earnings and multiples data:
APLS - Net Financial Result|Expected Profit Apellis Pharmaceuticals|APLS - Business Payback Period|Projected Price to Earnings Apellis|APLS - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Apellis|APLS - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Apellis Pharmaceuticals|APLS - Earnings per share for the trailing year|Quarterly EPS earnings growth apellis.com|APLS - Earnings growth in current year|Net earnings per share growth forecast for next year Apellis Pharmaceuticals
Basic company analysis:APLS - Apellis Pharmaceuticals
Mass-produced product of Apellis Pharmaceuticals, Inc.

For Apellis Pharmaceuticals (APLS), which is scaling the expansion of its drug against geographic atrophy, this indicator serves as a measure of efficiency in transitioning from the investment phase to real revenue generation. By analyzing the fundamental TTM net income per share metric, an investor evaluates the final annual financial result divided by the total number of shares, which allows for the determination of the real value of each business stake and an assessment of the risk of overpaying for the asset.

Competitor analysis for Apellis Pharmaceuticals

ALC: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months bausch.com|GKOS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Belite Bio Pharma (BLTE)|Earnings per share for the last twelve months Ocular Therapeutix Corp|Harrow Corp (HROW) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) VRDN|Net earnings per share (EPS TTM) lenz-tx.com (LENZ)|Earnings per share for the last twelve months Oculis Holding OCS|EYPT (EyePoint Pharmaceuticals Inc) - Earnings per one share for the last 12 months|Kodiak Pharma - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aldeyra Therapeutics|kalarx.com (KALA) - Earnings per share for the last twelve months|IRD (Opus Genetics) - Earnings per share for the last twelve months|Earnings per share for the last twelve months OKYO Pharma Ltd|Earnings per share for the last twelve months ADVM|Net earnings per share (EPS TTM) OTLK|Net earnings per share for the last four quarters Clearside Corp|Earnings per share for the last twelve months NovaBay Pharmaceuticals, Inc. NBY|Net earnings per share for the last four quarters Kiora Pharmaceuticals Inc. (KPRX)|ALIM: Net earnings per share for the last 12 months|Earnings per share for the trailing year EYEN (Eyenovia, Inc.)|Guardion Health Sciences Inc. (GHSI) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months OCUP (Ocuphire Corporation)|OPT (Opthea Limited) - Net earnings per share (EPS TTM)